广州医药研究总院

Guangzhou General Pharmaceutical Research Institute (GGPRI) is a leading comprehensive pharmaceutical research and development institution in China, serving as the core R&D engine for Guangzhou Pharmaceutical Holdings Limited (GPHL). Founded in 1972, the institute specializes in drug discovery, safety evaluation (GLP), and pharmaceutical engineering. It operates several national-level platforms, including the National Canine Laboratory Animal Resource Center and a National Key Laboratory for New Drug Safety Evaluation. GGPRI provides a wide range of services including preclinical research, quality standard development, and technology transfer for both traditional Chinese medicine (TCM) and chemical drugs.